Oncostellae logo

Oncostellae jobs and careers

Orense, Spain

About Oncostellae

Oncostellae has been founded in 2013 by a group of researchers (chemists, biochemists and pharmacologists) who have a common track record in developing clinical drug candidates until phase II. Our objective is to discover and develop small molecule drugs for the treatment of cancer by generating pharmaceutical research programs around novelmodulators of validated cancer targets like e.g. nuclear receptors and kinases. The company’s strategy includes running the discovery and development process with limited headcounts and focusing internal activities on project management, medicinal chemistry and in vitro pharmacology. The remaining activities of the R&D process like in vivo pharmacology, toxicology and clinical trials are subcontracted to qualified providers.The commercial goal is to license a clinical drug candidate including intellectual property and preclinical/clinical data package to a consolidated pharmaceutical or biotechnological company.

Founded in 2013 by Julio Castro-Palomino and Maribel Cadavid.

Founded
2013
Employees
11 to 50
Total funding
$4.4M
Headquarters
Orense

Leadership

The top of Oncostellae's org chart, with how many people report into each leader.

GKPhoto of Guido Kurz

Guido Kurz

CEO

8 reports

CB

Cristina Balagué

Chief Scientific Officer

3 reports

ACPhoto of Agustí Soler Casas

Agustí Soler Casas

Interin CFO & Board Observer

1 report

ARPhoto of Ascensión Heredia Rodríguez

Ascensión Heredia Rodríguez

Chief Operating Officer

1 report